These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 487531)
21. On the mechanism of L-dopa-induced postural hypotension in the cat. Dhasmana KM; Spilker BA Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189 [TBL] [Abstract][Full Text] [Related]
22. Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats. Galindo P; González-Manzano S; Zarzuelo MJ; Gómez-Guzmán M; Quintela AM; González-Paramás A; Santos-Buelga C; Pérez-Vizcaíno F; Duarte J; Jiménez R Food Funct; 2012 Jun; 3(6):643-50. PubMed ID: 22441211 [TBL] [Abstract][Full Text] [Related]
23. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor. Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053 [No Abstract] [Full Text] [Related]
24. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats. Rankin GO; Watkins BE; Sawutz DG Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417 [TBL] [Abstract][Full Text] [Related]
25. Studies on the mode of action of alpha-methyldopa. Henning M Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985 [No Abstract] [Full Text] [Related]
26. Chronic ethanol administration attenuates imidazoline I1 receptor- or alpha 2-adrenoceptor-mediated reductions in blood pressure and hemodynamic variability in hypertensive rats. El-Mas MM; Abdel-Rahman AA Eur J Pharmacol; 2004 Feb; 485(1-3):251-62. PubMed ID: 14757148 [TBL] [Abstract][Full Text] [Related]
27. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351 [TBL] [Abstract][Full Text] [Related]
28. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase. Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998 [No Abstract] [Full Text] [Related]
29. Enhancement of the anti-hypertensive effect of methyldopa and other anti-hypertensive drugs by carbidopa in spontaneously hypertensive rats. Scriabine A; Ludden CT; Stone CA; Wurtman RJ; Watkins CJ Clin Sci Mol Med Suppl; 1976 Dec; 3():407s-410s. PubMed ID: 1071655 [TBL] [Abstract][Full Text] [Related]
30. Dietary protein intake influences the antihypertensive potency of methyldopa in spontaneously hypertensive rats. Sved AF; Goldberg IM; Fernstrom JD J Pharmacol Exp Ther; 1980 Jul; 214(1):147-51. PubMed ID: 7391965 [TBL] [Abstract][Full Text] [Related]
31. Site of action of methyldopa in lowering the blood pressure in man. Kersting F; Reid JL; Dollery CT Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299 [TBL] [Abstract][Full Text] [Related]
32. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester. Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa. Jung MJ; Hornsperger JM; Gerhart F; Wagner J Biochem Pharmacol; 1984 Jan; 33(2):327-30. PubMed ID: 6704155 [No Abstract] [Full Text] [Related]
34. Effect of alpha-methyl fluorodopa on dopamine metabolites: importance of conjugation and egress. Sarna GS; Hutson PH; Curzon G Eur J Pharmacol; 1984 May; 100(3-4):343-50. PubMed ID: 6203763 [TBL] [Abstract][Full Text] [Related]
35. Rigid amino acids related to alpha-methyldopa. Cannon JG; O'Donnell JP; Rosazza JP; Hoppin CR J Med Chem; 1974 May; 17(5):565-8. PubMed ID: 4830265 [No Abstract] [Full Text] [Related]
36. Synthesis and antihypertensive activity of some ester progenitors of methyldopa. Saari WS; Freedman MB; Hartman RD; King SW; Raab AW; Randall WC; Engelhardt EL; Hirschmann R; Rosegay A; Ludden CT; Scriabine A J Med Chem; 1978 Aug; 21(8):746-53. PubMed ID: 691000 [TBL] [Abstract][Full Text] [Related]
37. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA]. BENZI G Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022 [No Abstract] [Full Text] [Related]
38. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats. Farsang C; Ramirez-Gonzalez MD; Mucci L; Kunos G J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627 [TBL] [Abstract][Full Text] [Related]
39. Effects of antihypertensive treatment on systolic blood pressure and renin in experimental hypertension in rats. Cangiano JL; Rodríguez-Sargent C; Martínez-Maldonado M J Pharmacol Exp Ther; 1979 Feb; 208(2):310-3. PubMed ID: 762665 [TBL] [Abstract][Full Text] [Related]
40. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat. Finch L; Haeusler G Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]